Erbitux adds 5 weeks to lung cancer survival
June 2, 2008 — CHICAGO (Reuters) - Lung cancer patients treated in a large clinical trial with ImClone Systems Inc's Erbitux and chemotherapy lived about five weeks longer than patients treated with chemotherapy alone, according to study results released on Saturday.
Fruit, veggies may lower head and neck cancer risk
May 23, 2008 — NEW YORK (Reuters Health) - People who eat plenty of fruits and vegetables may have a lower risk of developing cancers of the head and neck.
Oral test could predict lung cancer, study finds
April 14, 2008 — WASHINGTON (Reuters) - Damage to cells lining the mouth can predict similar damage in the lungs that eventually leads to lung cancer in smokers, U.S. researchers reported on Sunday.
Select news items provided by Reuters Health